Global X S&P Biotech ETF (ASX:CURE)

ASX:CURE Holdings Information

ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Apellis Pharmaceuticals stock at 1.72%, Revolution Medicines at 1.57%, Summit Therapeutics at 1.52%, Travere Therapeutics at 1.45%, and Twist Bioscience at 1.34%.

• Total Holdings: 10
• Top 10 Percentage: 14.10%
• Asset Class: Equity
• ETF Category: Health Care
• Assets: 41.74M
• PE Ratio: n/a

Top 25 Holdings

As of Apr 20, 2026

Filter results

No.	Symbol	Name	% Weight	Shares
1	APLS	Apellis Pharmaceuticals, Inc.	1.72%	12,788
2	RVMD	Revolution Medicines, Inc.	1.57%	3,209
3	SMMT	Summit Therapeutics Inc.	1.52%	18,357
4	TVTX	Travere Therapeutics, Inc.	1.45%	10,801
5	TWST	Twist Bioscience Corporation	1.34%	6,820
6	TGTX	TG Therapeutics, Inc.	1.32%	11,394
7	ALKS	Alkermes plc	1.31%	11,509
8	APGE	Apogee Therapeutics, Inc.	1.30%	4,280
9	MDGL	Madrigal Pharmaceuticals, Inc.	1.30%	741
10	BEAM	Beam Therapeutics Inc.	1.27%	12,255